How long is the half-life of Ticlopidine?

The half-life of Ticlopidine is an important pharmacokinetic parameter that informs clinicians about how long the drug remains active in the body and how often it should be administered. In this case, the half-life of Ticlopidine is approximately 24 to 36 hours.

This information is particularly relevant because it helps to understand the dosing schedule required for optimal therapeutic effect. A half-life in this range indicates that after 24 to 36 hours, about half of the medication will be eliminated from the body, guiding the healthcare provider in determining when to administer the next dose.

While other options present different ranges, 24-36 hours accurately reflects Ticlopidine's pharmacokinetics based on clinical studies and established data. Understanding the half-life aids in anticipating potential side effects, interactions with other medications, and overall patient management regarding antiplatelet therapy.